Menu
Back to Journals » International Journal of Nanomedicine » Volume 10 » Issue 1
Development of polymeric–cationic peptide composite nanoparticles, a nanoparticle-in-nanoparticle system for controlled gene delivery
Authors Jain AK, Massey A, Yusuf H, McDonald D, McCarthy H, Kett VL
Received 27 August 2015
Accepted for publication 7 October 2015
Published 24 November 2015 Volume 2015:10(1) Pages 7183—7196
DOI https://doi.org/10.2147/IJN.S95245
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Thomas J Webster
Arvind K Jain,1,2 Ashley Massey,1 Helmy Yusuf,1 Denise M McDonald,3 Helen O McCarthy,1 Vicky L Kett1
1School of Pharmacy, Medical Biology Centre, Queen’s University Belfast, Belfast, Northern Ireland, UK, 2Weatherall Institute of Molecular Medicine, MRC Molecular Haematology Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK, 3Centre for Vision & Vascular Science, Queen’s University Belfast, Belfast, Northern Ireland, UK
Abstract: We report the formulation of novel composite nanoparticles that combine the high transfection efficiency of cationic peptide-DNA nanoparticles with the biocompatibility and prolonged delivery of polylactic acid–polyethylene glycol (PLA-PEG). The cationic cell-penetrating peptide RALA was used to condense DNA into nanoparticles that were encapsulated within a range of PLA-PEG copolymers. The composite nanoparticles produced exhibited excellent physicochemical properties including size <200 nm and encapsulation efficiency >80%. Images of the composite nanoparticles obtained with a new transmission electron microscopy staining method revealed the peptide-DNA nanoparticles within the PLA-PEG matrix. Varying the copolymers modulated the DNA release rate >6 weeks in vitro. The best formulation was selected and was able to transfect cells while maintaining viability. The effect of transferrin-appended composite nanoparticles was also studied. Thus, we have demonstrated the manufacture of composite nanoparticles for the controlled delivery of DNA.
Keywords: PLA-PEG, cationic peptide, gene delivery, composite nanoparticles, DNA, transfection
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.